News ProPhase Labs, Inc.

Equities

PRPH

US74345W1080

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
5.44 ^USD	-13.24%		-15.00%	+20.35%

Apr. 16	Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup	DJ
Apr. 16	ProPhase Labs, Inc. Unveils Project ZenQ-AI	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup	Apr. 16	DJ
ProPhase Labs Unveils Project ZenQ-AI	Apr. 16	AQ
ProPhase Labs, Inc. Unveils Project ZenQ-AI	Apr. 16	CI
ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024	Apr. 10	AQ
ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	Apr. 01	AQ
MENADNA and ProPhase Labs' (NASDAQ: PRPH) Wholly-Owned Subsidiary, Nebula Genomics, Announce Strategic Partnership to Enhance Genomic Testing in Jordan, Oman and Iraq	Mar. 18	AQ
Transcript : ProPhase Labs, Inc., 2023 Earnings Call, Mar 15, 2024	Mar. 15
ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives	Mar. 15	AQ
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
North American Morning Briefing : Inflation -2-	Mar. 15	DJ
PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024	Mar. 08	AQ
ProPhase Labs Announces Significant Progress in BE-Smart Esophageal Cancer Test Development USPTO grants additional broad patents for BE-SMART	Feb. 20	AQ
Prophase Labs, Inc. Announces Important Developments in the Company?s Efforts to Commercialize Its Novel Be-Smart Esophageal Cancer Diagnostic Test	Feb. 20	CI
ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir	Feb. 14	AQ
ProPhase Labs, Inc. Announces Preliminary Positive Results for Dietary Supplement Equivir	Feb. 14	CI
Sidus Space Appoints Bill White as Chief Financial Officer	Feb. 09	AQ
ProPhase Labs Ushers in New Genomics Era with Jason Karkus at the Helm of Nebula Genomics	Jan. 30	AQ
Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts	Jan. 23	AQ
ProPhase Labs Names Jed Latkin as Chief Operating Officer	Jan. 04	MT
ProPhase Labs, Inc. Appoints Jed Latkin as COO	Jan. 04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ProPhase Labs, Inc.

Equities

PRPH

US74345W1080

Summary

Filters